A fatal case of cholestatic liver failure probably related to gemcitabine

被引：16

作者：

Coeman, DC

Verbeken, EK

Nackaerts, KL

Demedts, MG

Vansteenkiste, JF ^{[1
]}

机构：

[1] Univ Hosp Gasthuisberg, Dept Pulmonol, Resp Oncol Unit, B-3000 Louvain, Belgium

[2] Univ Hosp Gasthuisberg, Dept Pathol, B-3000 Louvain, Belgium

来源：

ANNALS OF ONCOLOGY | 2000年 / 11卷 / 11期

关键词：

D O I：

10.1023/A:1026514527313

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1503 / 1503

页数：1

共 7 条

[1] Gemcitabine - a safety review [J].

Aapro, MS ;

Martin, C ;

Hatty, S .

ANTI-CANCER DRUGS, 1998, 9 (03) :191-201

[2] Safety profile of gemcitabine, a novel anticancer agent, in non-small cell lung cancer [J].

CortesFunes, H ;

Martin, C ;

Abratt, R ;

Lund, B .

ANTI-CANCER DRUGS, 1997, 8 (06) :582-587

[3] Veno-occlusive disease of the liver induced by gemcitabine [J].

Dobbie, M ;

Hofer, S ;

Oberholzer, M ;

Herrmann, R .

ANNALS OF ONCOLOGY, 1998, 9 (06) :681-681

[4]

MAJERUS PW, 1996, GOODMAN GILMANS PHAR, P1343

[5] Single-agent gemcitabine versus cisplatin-etoposide: Early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer [J].

Manegold, C ;

Bergman, B ;

Chemaissani, A ;

Dornoff, W ;

Drings, P ;

KellokumpuLehtinen, P ;

Liippo, K ;

Mattson, K ;

vonPawel, J ;

Ricci, S ;

Sederholm, C ;

Stahel, RA ;

Wagenius, G ;

vonWalree, N ;

tenBokkelHuinink, W .

ANNALS OF ONCOLOGY, 1997, 8 (06) :525-529

[6] Phase I trial of gemcitabine (Gemzar®, 24 h infusion 5-fluorouracil and folinic acid in patients with inoperable pancreatic cancer [J].

Oettle, H ;

Pelzer, U ;

Hochmuth, K ;

Diebold, T ;

Langrehr, J ;

Schmidt, CA ;

Arning, M ;

Vogl, TJ ;

Neuhaus, P ;

Huhn, D ;

Riess, H .

ANTI-CANCER DRUGS, 1999, 10 (08) :699-704

[7] Safety profile of gemcitabine [J].

Tonato, M ;

Mosconi, AM ;

Martin, C .

ANTI-CANCER DRUGS, 1995, 6 :27-32

← 1 →